Anika Therapeutics, Inc. (ANIK) Tops Q1 Revenue Tops Views
Get Alerts ANIK Hot Sheet
Price: $25.60 -1.16%
EPS Growth %: -63.6%
Financial Fact:
Research & development: 2.82M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: -63.6%
Financial Fact:
Research & development: 2.82M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q1 EPS of $0.97, $0.72 better than the analyst estimate of $0.25. Revenue for the quarter came in at $34 million versus the consensus estimate of $16.03 million.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Union Pacific (UNP) Tops Q1 EPS by 18c
- United Bankshares (UBSI) Misses Q1 EPS by 1c
- Equinor ASA (EQNR) Tops Q1 EPS by 22c, misses on revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!